Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04235257 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intradermal, Fractional Dose of HPV Vaccines:

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Re-verified, no change to tracked fieldsv7
  2. Primary and study completion dates: Dec 31, 2024 to Dec 31, 2026v6
  3. Primary and study completion dates: Dec 31, 2023 to Dec 31, 2024v5
  4. Re-verified, no change to tracked fieldsv4
  5. Primary and study completion dates: Dec 31, 2022 to Dec 31, 2023v3
  6. Start date changed from estimate of Mar 1, 2020 to Nov 1, 2020 Trial status: Not Yet Recruiting to Active, Not Recruiting · Study sites: 0 to 1v2 Show 2 more changesShow less
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study sites: 0 to 1
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized phase IV trial compares fractional dose of bivalent HPV vaccine to fractional dose of nonavalent HPV vaccine among men and women aged 27-45 years in Seattle, Washington. Participants will have immune response assessed at baseline, 4 weeks, 6 months, 12 months, and 24 months.
Trial Details
NCT Number NCT04235257
Lead Sponsor University of Washington
Conditions HPV Infection, HPV Vaccine
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov